Neural Tube Defects is a topic covered in the Select 5-Minute Pediatrics Topics.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

Basics

Description

Neural tube defects (NTDs): CNS malformations due to abnormalities of neural tube closure during early embryonic development and include anencephaly, encephalocele, and spina bifida (SB)

  • Open NTDs: Exposed neural tissue and membranes protrude through a bony defect and lack a skin covering.
    • Due to failure of primary neural tube closure during the 3rd and 4th weeks after fertilization
    • Include anencephaly, craniorachischisis, myelomeningocele, and myeloschisis
  • Closed NTDs: theorized to be due to defects of secondary neurulation. Less common than open NTDs and are skin covered.
    • Include some encephaloceles and various types of occult spinal dysraphism (OSD)
  • Anencephaly: due to failed closure of rostral neural tube with total or partial absence of cranial vault and cerebral hemispheres
  • Encephalocele: partial failure of rostral neural tube closure
    • Abnormal brain tissue protrudes through a skull defect usually covered by skin.
    • 70–80% are occipital, 20% are frontal.
    • 10–20% of occipital defects are meningoceles and contain no brain tissue.
  • SB: means “spine split in two” and includes open and closed types
    • Myelomeningocele (MMC): open NTD of the spine, most common type of SB, and characterized by herniation of dysplastic spinal cord and meninges through a posterior vertebral column defect
    • Closed SB: often not diagnosed at birth and often referred to as occult spinal dysraphism.
      • Intact skin over the defect
      • Wide spectrum of defects including lipomyelomeningocele, dermal sinus tracts, diastematomyelia (split cord malformations), myelocystocele, other tumors and cysts of the cord, and congenital spinal cord tethering

Epidemiology

Prevalence

  • NTDs affect ∼1 in 1,000 established pregnancies worldwide, with significant geographic variation.
  • In the United States, birth prevalence has been decreasing due to periconceptional supplementation with folic acid as well as prenatal diagnosis and termination of pregnancy.
  • CDC data from 2004 to 2006 showed 0.64 NTDs per 1,000 births (∼2,660 cases per year), with 54% classified as SB, 32% anencephaly, and 13% encephalocele.

Risk Factors

Most NTDs are due to the interaction of genetic, environmental, and dietary risk factors.

  • Variants of multiple genes probably confer some increased genetic susceptibility.
  • Maternal nutrition and dietary factors
    • Inadequate maternal folic acid intake
  • Maternal diabetes mellitus
  • Maternal obesity
  • Maternal use of valproic acid (10× risk), carbamazepine, or alcohol during pregnancy
  • Maternal exposure to hyperthermia during early pregnancy (e.g., sauna, hot tub, fever)

Genetics

  • In most NTD cases, a specific genetic cause is not found.
  • Positive family history in ∼5% NTD cases
  • After 1 child with an NTD, the recurrence rate is 2–5% for subsequent pregnancies.
  • A chromosomal or cytogenetic abnormality in ∼10% of isolated NTDs, higher percentage in those with multiple congenital anomalies
  • NTDs common in trisomy 13 and 18 and can be seen with duplications and deletions.
  • Also seen as in single gene disorders or syndromes (e.g., Meckel, Waardenburg, 22q11 deletion syndromes)
  • A number of candidate risk factor genes have been studied; the most implicated are those in the folate one-carbon metabolic pathway.
    • A homozygous 677C>T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene in mother or child is associated with ∼1.8 times increased risk.

General Prevention

  • Periconceptual folic acid supplementation has the potential to reduce NTDs by 50–70%.
  • Because many pregnancies are not identified until after neural tube closure occurs, and because more than 50% of pregnancies are unplanned, the CDC recommends that all women of childbearing age receive a minimum of 0.4 mg (400 mcg) of folic acid daily.
  • Women at high risk (prior pregnancy with NTD, on valproic acid, etc.) should take high-dose folic acid (4 mg daily), starting 1 month before and through the first 3 months of pregnancy.
  • If taking valproic acid, consider switching to alternative medication during pregnancy.

Commonly Associated Conditions

  • Open SB is virtually always associated with some malformation of the brain.
  • Most children with MMC have a Chiari II (Arnold-Chiari) malformation, small posterior fossa with elongation of the cerebellum, and herniation through the foramen magnum.
    • Chiari II malformation often causes obstructive hydrocephalus.
    • Historically, about 80% of children with MMC required a CSF shunt.
  • Callosal dysgenesis, cortical dysplasia, and subependymal heterotopias are also common.
  • MMC is commonly associated with nonverbal learning disabilities and executive dysfunction.
  • Open and closed SB: impairments directly due to spinal cord dysfunction:
    • Paraparesis and sensory loss usually correlating with the level of the lesion
    • Neurogenic bladder dysfunction
    • Neurogenic bowel dysfunction
  • Congenital foot deformities (club foot) and hip dysplasia are common with NTDs.

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Neural Tube Defects ID - 14003 Y1 - 2015 PB - Select 5-Minute Pediatrics Topics UR - https://im.unboundmedicine.com/medicine/view/Select-5-Minute-Pediatric-Consult/14003/all/Neural_Tube_Defects ER -